Dicot Pharma AB Sustainability Reports
Dicot Pharma AB is a drug development company focused on increasing quality of life and well-being through innovations that enhance sexual health. The company primarily develops its lead candidate, LIB-01, as a potency drug for treating erectile dysfunction and premature ejaculation.
Sector: Manufacturing
Country: Sweden
Exchange: Nasdaq Stockholm
LEI: 549300GX132RSE4OV407
FIGI: BBG00KT8LY62
8 reports from 2018 to 2025
